Nicole Afacan

645 total citations
10 papers, 526 citations indexed

About

Nicole Afacan is a scholar working on Immunology, Microbiology and Molecular Biology. According to data from OpenAlex, Nicole Afacan has authored 10 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Microbiology and 2 papers in Molecular Biology. Recurrent topics in Nicole Afacan's work include Antimicrobial Peptides and Activities (5 papers), Immune Response and Inflammation (3 papers) and CAR-T cell therapy research (2 papers). Nicole Afacan is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Immune Response and Inflammation (3 papers) and CAR-T cell therapy research (2 papers). Nicole Afacan collaborates with scholars based in Canada, Germany and China. Nicole Afacan's co-authors include Robert E. W. Hancock, Olga M. Pena, Amy Yeung, Laurence Madera, Christopher D. Fjell, Reza Falsafi, Håvard Jenssen, Matthias Schulte, François Niyonsaba and Frank Jacobsen and has published in prestigious journals such as PLoS ONE, Biomaterials and Cancer Research.

In The Last Decade

Nicole Afacan

9 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Afacan Canada 6 356 244 177 54 40 10 526
Han-Ning Huang Taiwan 14 334 0.9× 251 1.0× 220 1.2× 29 0.5× 10 0.3× 16 561
Kris De Smet Belgium 6 277 0.8× 369 1.5× 141 0.8× 38 0.7× 33 0.8× 7 691
Chongbing Liao China 9 182 0.5× 294 1.2× 71 0.4× 43 0.8× 17 0.4× 16 494
Viktoria A. F. Schneider Netherlands 9 343 1.0× 237 1.0× 165 0.9× 26 0.5× 22 0.6× 9 429
Morgan A. Alford Canada 9 296 0.8× 277 1.1× 70 0.4× 63 1.2× 8 0.2× 21 482
Radha M. Golla United States 11 374 1.1× 340 1.4× 77 0.4× 68 1.3× 11 0.3× 11 480
A. El Ghalbzouri Netherlands 6 355 1.0× 344 1.4× 56 0.3× 101 1.9× 11 0.3× 8 679
Lixian Mu China 16 483 1.4× 284 1.2× 163 0.9× 57 1.1× 16 0.4× 28 693
Sheng‐An Li China 12 165 0.5× 172 0.7× 95 0.5× 32 0.6× 7 0.2× 14 388

Countries citing papers authored by Nicole Afacan

Since Specialization
Citations

This map shows the geographic impact of Nicole Afacan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Afacan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Afacan more than expected).

Fields of papers citing papers by Nicole Afacan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Afacan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Afacan. The network helps show where Nicole Afacan may publish in the future.

Co-authorship network of co-authors of Nicole Afacan

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Afacan. A scholar is included among the top collaborators of Nicole Afacan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Afacan. Nicole Afacan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Afacan, Nicole, et al.. (2025). Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers. Cancer Research. 85(8_Supplement_1). 3503–3503. 1 indexed citations
2.
Poffenberger, Maya C., Alexandra Livernois, Chayne L. Piscitelli, et al.. (2024). Abstract 6719: TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated CD28 costimulation, engineered to improve responses in the treatment of solid tumors. Cancer Research. 84(6_Supplement). 6719–6719.
3.
Escalante, Nichole, et al.. (2023). Abstract 5121: TriTCE Co-stim, next generation costimulatory trispecific T cell engagers for the treatment of solid tumors. Cancer Research. 83(7_Supplement). 5121–5121. 2 indexed citations
4.
Yang, Hong, Lisa K. Kozicky, Aabida Saferali, et al.. (2016). Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials. 111. 90–102. 58 indexed citations
5.
Afacan, Nicole. (2016). Linking cellular metabolism and Innate Defence Regulator peptide function. Open Collections. 1 indexed citations
6.
Pena, Olga M., Nicole Afacan, Jelena Pistolic, et al.. (2013). Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation. PLoS ONE. 8(1). e52449–e52449. 77 indexed citations
7.
Niyonsaba, François, Laurence Madera, Nicole Afacan, et al.. (2013). The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions. Journal of Leukocyte Biology. 94(1). 159–170. 73 indexed citations
8.
Afacan, Nicole, Amy Yeung, Olga M. Pena, & Robert E. W. Hancock. (2012). Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections. Current Pharmaceutical Design. 18(6). 807–819. 163 indexed citations
9.
Steinstraesser, Lars, Tobias Hirsch, Matthias Schulte, et al.. (2012). Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection. PLoS ONE. 7(8). e39373–e39373. 129 indexed citations
10.
Afacan, Nicole, Christopher D. Fjell, & Robert E. W. Hancock. (2011). A systems biology approach to nutritional immunology – Focus on innate immunity. Molecular Aspects of Medicine. 33(1). 14–25. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026